- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
Aptorum To Start Testing SACT-1 In Neuroblastoma Patients
September 15, 2021
Tickers
APM
From Benzinga
ATyr Pharma's Lead Candidate Shows Promise In Inflammatory Lung Disease
September 13, 2021
Tickers
LIFE
From Benzinga
Adaptimmune Shares Encouraging Data From Solid Tumor Trial
September 13, 2021
Tickers
ADAP
From Benzinga
Why Are Mersana Therapeutics Shares Trading Lower On Friday?
September 10, 2021
Tickers
MRSN
From Benzinga
Decibel Therapeutics' Hearing Loss Gene Therapy Receives FDA Orphan Drug Tag
September 09, 2021
Tickers
DBTX
From Benzinga
Precision BioSciences, iECURE Ink Licensing Pact For Gene Editing Therapies
September 09, 2021
Tickers
DTIL
From Benzinga
Vor Biopharma's Lead Hematopoietic Stem Cell Candidate Fast Tracked In US
September 09, 2021
Tickers
VOR
From Benzinga
Why Are Investors Cheering Cardiff Oncology's New Data In Colorectal Cancer Setting?
September 09, 2021
Tickers
CRDF
From Benzinga
Novavax Starts COVID-19, Flu Combination Vaccine Trial
September 08, 2021
Tickers
NVAX
From Benzinga
FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder
September 07, 2021
Tickers
BMRN
From Benzinga
What Is Happening With Scopus BioPharma Stock On Thursday?
September 02, 2021
Tickers
SCPS
From Benzinga
From Benzinga
Brickell Biotech Acquires Rights To Candidate For Autoimmune Diseases
September 01, 2021
Tickers
BBI
From Benzinga
Aileron Unveils Initial Data For Its Chemo Protective Agent
August 27, 2021
Tickers
ALRN
From Benzinga
INmune Bio Stock Jumps On Promising Biomarker Data From Early-Stage Blood Cancer Trial
August 26, 2021
Tickers
INMB
From Benzinga
Why Is Flexion Therapeutics (FLXN) Stock Gaining On Wednesday?
August 25, 2021
Tickers
FLXN
From Benzinga
Johnson & Johnson COVID-19 Booster Shot Generates 9X Spike-Binding Antibodies, Early Data Shows
August 25, 2021
Tickers
JNJ
From Benzinga
Why Bio-Path Shares Are Moving Higher In Premarket Tuesday?
August 24, 2021
Tickers
BPTH
From Benzinga
From Benzinga
Why Is Plus Therapeutics Stock Rising After Data Presentation From Brain Tumor Trial?
August 23, 2021
Tickers
PSTV
From Benzinga
Fate Therapeutics' Stem Cell-Derived NK Lymphoma Candidate Casts Doubt Over Durability Of Response
August 20, 2021
Tickers
FATE
From Benzinga
Compugen's Out-Licensed Lung Cancer Candidate Enters Human Trial
August 19, 2021
From Benzinga
Cabaletta Bio's Cell Therapy Shows Encouraging Safety Profile In Autoimmune Skin Disorder
August 18, 2021
Tickers
CABA
From Benzinga
Sutro Biopharma's Ovarian Cancer Candidate Fast Tracked In US
August 18, 2021
Tickers
STRO
From Benzinga
Alzamend Recruits Altasciences To Conduct Early-Stage Trial Of Its Alzheimer's Candidate
August 17, 2021
Tickers
ALZN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.